Literature DB >> 30046863

Contribution of cocaine-related cues to concurrent monetary choice in humans.

Justin C Strickland1, Katherine R Marks2, Joshua S Beckmann1, Joshua A Lile1,2,3, Craig R Rush1,2,3, William W Stoops4,5,6,7.   

Abstract

RATIONALE: Theoretical accounts highlight the importance of drug-related cues for the development and persistence of drug-taking behavior. Few studies have evaluated the ability of spatially contiguous drug cues to bias decisions between two concurrently presented non-drug reinforcers.
OBJECTIVE: Evaluate the contribution of spatially contiguous cocaine cues to choice between two concurrently presented monetary reinforcers
METHODS: Participants with cocaine use disorder completed a cued concurrent choice task. Two cues (one cocaine and one control image) were presented side-by-side followed by concurrent monetary offers below each image. Concurrent choice was measured for cocaine-side advantageous, equal, and disadvantageous concurrent monetary offers. The primary dependent measure was bias for selecting cocaine-cued monetary reinforcers. Three experiments tested selectivity of cocaine-cued bias in individuals with a cocaine use history (Experiment 1), replication when including additional control trials (Experiment 2), and a potential attentional mechanism evaluated using eye-tracking technology (Experiment 3).
RESULTS: Significant and robust cocaine-cued bias at equal monetary value was observed in three experiments (mean percent choice = 65-77%) and higher Drug Abuse Screening Test (DAST) scores were associated with greater cocaine-choice bias. These experiments demonstrated that cocaine-cued bias was (1) selective to individuals with a cocaine use history, (2) specific to trials involving a cocaine cue, and (3) partially associated with attentional bias.
CONCLUSIONS: These experiments provide evidence that drug-related cues can influence choice and potentially promote maladaptive decision making during concurrent choice events. Future research evaluating prospective associations of drug-cued bias with drug-associated behaviors will help reveal the clinical relevance for substance use disorder.

Entities:  

Keywords:  Addiction; Conditioning; Cue; Drug; Salience

Mesh:

Substances:

Year:  2018        PMID: 30046863      PMCID: PMC6162111          DOI: 10.1007/s00213-018-4978-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

Review 1.  Neuroscience of attentional processes for addiction medicine: from brain mechanisms to practical considerations.

Authors:  Javad Salehi Fadardi; W Miles Cox; Arash Rahmani
Journal:  Prog Brain Res       Date:  2015-11-23       Impact factor: 2.453

2.  Test-retest reliability of eye tracking during the visual probe task in cocaine-using adults.

Authors:  Katherine R Marks; Erika Pike; William W Stoops; Craig R Rush
Journal:  Drug Alcohol Depend       Date:  2014-10-16       Impact factor: 4.492

3.  The magnitude of drug attentional bias is specific to substance use disorder.

Authors:  Katherine R Marks; Erika Pike; William W Stoops; Craig R Rush
Journal:  Psychol Addict Behav       Date:  2015-05-11

4.  Acquisition of responses to a methamphetamine-associated cue in healthy humans: self-report, behavioral, and psychophysiological measures.

Authors:  Leah M Mayo; Harriet de Wit
Journal:  Neuropsychopharmacology       Date:  2015-01-20       Impact factor: 7.853

5.  Demand curves for hypothetical cocaine in cocaine-dependent individuals.

Authors:  Natalie R Bruner; Matthew W Johnson
Journal:  Psychopharmacology (Berl)       Date:  2013-11-12       Impact factor: 4.530

6.  Enhanced choice for viewing cocaine pictures in cocaine addiction.

Authors:  Scott J Moeller; Thomas Maloney; Muhammad A Parvaz; Jonathan P Dunning; Nelly Alia-Klein; Patricia A Woicik; Greg Hajcak; Frank Telang; Gene-Jack Wang; Nora D Volkow; Rita Z Goldstein
Journal:  Biol Psychiatry       Date:  2009-04-09       Impact factor: 13.382

7.  The role of 'jackpot' stimuli in maladaptive decision-making: dissociable effects of D1/D2 receptor agonists and antagonists.

Authors:  Aaron P Smith; Rebecca S Hofford; Thomas R Zentall; Joshua S Beckmann
Journal:  Psychopharmacology (Berl)       Date:  2018-02-18       Impact factor: 4.530

8.  Fixation time is a sensitive measure of cocaine cue attentional bias.

Authors:  Katherine R Marks; Walter Roberts; William W Stoops; Erika Pike; Mark T Fillmore; Craig R Rush
Journal:  Addiction       Date:  2014-07-02       Impact factor: 6.526

9.  A novel concurrent pictorial choice model of mood-induced relapse in hazardous drinkers.

Authors:  Lorna Hardy; Lee Hogarth
Journal:  Exp Clin Psychopharmacol       Date:  2017-12       Impact factor: 3.157

10.  Drug cue reactivity involves hierarchical instrumental learning: evidence from a biconditional Pavlovian to instrumental transfer task.

Authors:  Lorna Hardy; Chris Mitchell; Tina Seabrooke; Lee Hogarth
Journal:  Psychopharmacology (Berl)       Date:  2017-04-15       Impact factor: 4.530

View more
  4 in total

1.  Contribution of cannabis-related cues to concurrent reinforcer choice in humans.

Authors:  Justin C Strickland; Joshua A Lile; William W Stoops
Journal:  Drug Alcohol Depend       Date:  2019-04-17       Impact factor: 4.492

2.  Contribution of alcohol- and cigarette-related cues to concurrent reinforcer choice in humans.

Authors:  Justin C Strickland; Cecilia L Bergeria
Journal:  Behav Processes       Date:  2020-04-17       Impact factor: 1.777

3.  Sexual discounting: A systematic review of discounting processes and sexual behavior.

Authors:  Matthew W Johnson; Justin C Strickland; Evan S Herrmann; Sean B Dolan; David J Cox; Meredith S Berry
Journal:  Exp Clin Psychopharmacol       Date:  2020-10-01       Impact factor: 3.157

Review 4.  Relative expected value of drugs versus competing rewards underpins vulnerability to and recovery from addiction.

Authors:  Lee Hogarth; Matt Field
Journal:  Behav Brain Res       Date:  2020-07-22       Impact factor: 3.332

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.